111 (NASDAQ: YI) — Perfil da empresa, notícias e dados financeiros
111 is a digital healthcare platform in China offering telemedicine, online pharmacy services and smart supply chain solutions.
111
111 is a digital healthcare platform company based in China that provides integrated online and offline pharmaceutical and medical services. Founded in 2010, the company connects patients with pharmaceutical products, medical providers, and healthcare insurance services through a technology-enabled supply chain and S2B2C business model. Its digital ecosystem comprises a B2C retail pharmacy platform, a B2B pharmaceutical marketplace, and an internet hospital system. The company delivers omni-channel commercialization solutions, smart supply chain management, and SaaS cloud tools for pharmaceutical manufacturers, retail pharmacies, physicians, and individual consumers across China.
Resumo
Operações
Produtos e/ou serviços de 111
- B2B Pharmaceutical Marketplace: Direct wholesale distribution network connecting pharmaceutical manufacturers and distributors with retail pharmacies, clinics, and medical facilities across China, facilitating bulk medicine procurement, order processing, and digital supply chain integration for business customers.
- B2C E-Commerce Pharmacy: Direct-to-consumer digital retail platform supplying prescription drugs, over-the-counter medicines, health supplements, and wellness products, offering online ordering, automated fulfillment, and home delivery services to individual consumers throughout China.
- Digital Internet Hospital Platform: Online medical consultation platform connecting patients with licensed physicians for remote consultations, electronic prescription issuance, chronic disease management, and digital health services integrated with medicine distribution networks.
- Omni-Channel Commercialization Services: Strategic partnership solutions for global and domestic pharmaceutical manufacturers, offering commercial drug launching, channel distribution, multi-channel marketing, and market access services across retail pharmacy networks and online digital platforms.
- Supply Chain and Logistics Infrastructure: Smart warehousing, cold-chain storage, inventory management, and nationwide fulfillment services tailored for pharmaceutical products, enabling rapid distribution and optimized drug delivery to pharmacy networks and healthcare institutions.
- Cloud and Software Services: Digital SaaS tools and cloud-based management systems provided to retail pharmacies and healthcare partners, enabling digitized inventory tracking, customer relationship management, online storefront operation, and data-driven business intelligence.
equipe executiva do 111
- Gang YuCo-Founder & Executive Chairman
- Junling LiuCo-Founder, Acting CFO, Chairman & CEO
- Monica MuIR Director
- Anfeng GuoChief Innovation Officer
- Alex LiuFinance Director
Últimas notícias sobre a 111
111 receives $4.52 ADS take-private offer
United States111 reports RMB2.3 billion Q2 revenue
United States111 revenue slips 33% as strategic shift to asset-light model continues
United States111 secures FY profitability following strategic shift to asset-light model
United States111 reports Q3 2025 results, shifts to asset-light model and strengthens cash flow
United States
Principais indicadores financeiros
Resultados divulgados pela 111, em CNY.
- Cap. de mercado
- 26,4 mi
- Receita (TTM)
- 10,5 bi
- P/L
- 0.3
- LPA (diluído, TTM)
- 10.3
- Dividend yield
- —
- Margem de lucro
- -1.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 12,2 bi | -10 mi | -16,8 mi | |
| 14,4 bi | 2,1 mi | -64,7 mi | |
| 14,9 bi | -350,1 mi | -392,7 mi | |
| 13,5 bi | -371 mi | -416,9 mi |